King Therapeutics LLC — Form D
King Therapeutics LLC of PHOENIX, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-15. The offering totals $500K, of which $310K was reported sold. Industry: Other.
Offering
- Filed: 2025-10-15
- Form: D
- Accession: 0002088073-25-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $310K
- Remaining: $190K
- Investors: 7
- Date of first sale: 2025-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-560923
Issuer
- Name: King Therapeutics LLC
- CIK: 0002088073
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 12006 S. 44TH ST., PHOENIX, AZ, 85044
- Phone: 602-516-2199
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Dmitry Derkach | Director | Gilbert, AZ |
| DAVID RICHARDSON | Director | VANCOUVER, A1 |
| Isaiah Slemons | Director | Tempe, AZ |
| DAVID RICHARDSON | Executive Officer | VANCOUVER, A1 |
More